KLKeun-Woo Lee

Keun-Woo Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Keun-Woo Lee has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Chang Ohk Sung

    Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

    1 shared publication
  • Hee Cheol Kim

    Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    1 shared publication
  • Insuk Sohn

    Arontier Inc., Gangnam-daero, Seoul, Republic of Korea

    1 shared publication
  • Jeong-Ryeol Gong

    Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea

    1 shared publication
  • Juhee Kim

    Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea

    1 shared publication
  • Kwang-Hyun Cho

    Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology

    1 shared publication

Latest Publications

  • Open Access

    PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression

    by Keun-Woo Lee, So-Young Yeo, Jeong-Ryeol Gong, Ok-Jae Koo, Insuk Sohn, Woo Yong Lee, Hee Cheol Kim, Seong Hyeon Yun, Yong Beom Cho, Mi-Ae Choi, et al.

    Although stromal fibroblasts play a critical role in cancer progression, their identities remain unclear as they exhibit high heterogeneity and plasticity. Here, a master transcription factor (mTF) constructing core-regulatory circuitry, PRRX1, which determines the fibroblast lineage with a myofibroblastic phenotype, is identified for the fibroblast subgroup. PRRX1 orchestrates the functional drift of fibroblasts into myofibroblastic phenotype via TGF-β signaling by remodeling a super-enhancer landscape. Such reprogrammed fibroblasts have myofibroblastic functions resulting in markedly enhanced tumorigenicity and aggressiveness of cancer. PRRX1 expression in cancer-associated fibroblast (CAF) has an unfavorable prognosis in multiple cancer types. Fibroblast-specific PRRX1 depletion induces long-term and sustained complete remission of chemotherapy-resistant cancer in genetically engineered mice models. This study reveals CAF subpopulations based on super-enhancer profiles including PRRX1. Therefore, mTFs, including PRRX1, provide another opportunity for establishing a hierarchical classification system of fibroblasts and cancer treatment by targeting fibroblasts.